COMMUNIQUÉS West-GlobeNewswire

Precision Therapeutics’ Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria
07/02/2019
MINNEAPOLIS, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY [...]
Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference
07/02/2019
Presentation will Highlight Progress in Celiac Disease Phase 3 Trial Timeline and NASH RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT) a clinical stage biotechnology [...]
Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases
07/02/2019
Gaining insights into inflammatory bowel disease through mass cytometry and Imaging Mass Cytometry analysis of the human mucosal immune system Research aimed at more precise treatments for IMIDs using existing therapies [...]
Aleafia Health Helps Patients & Investors with Revenue Generating Research -- CFN Media
07/02/2019
SEATTLE, Wash., Feb. 07, 2019 (GLOBE NEWSWIRE) -- -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Uptick Newswire Hosts Digipath, Inc. on the Stock Day Podcast to Discuss Their Increasing Revenues and the Launch of GroSciences
07/02/2019
PHOENIX, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Digipath, Inc. (DIGP), a service-oriented independent testing laboratory, data and media firm focused on the developing cannabis and [...]
Auxly Announces Termination of FSD Pharma Joint Venture
07/02/2019
VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced the termination of the definitive agreement dated March 3, 2018 (the [...]
Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease
07/02/2019
LA JOLLA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the U.S. Food and Drug [...]
Momenta Pharmaceuticals Announces Oral Presentation of New Data for M281 at the Society for Maternal-Fetal Medicine 2019 Annual Meeting
07/02/2019
Study highlights ability of M281 to inhibit transfer of immunoglobulin G from maternal to fetal circulation in ex vivo placental perfusion model M281 currently being evaluated in an international Phase 2 study in [...]
Evelo Biosciences to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 14, 2019
07/02/2019
CAMBRIDGE, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials, a potential new modality of oral biologic [...]
Forty Seven Inc. to Present at Guggenheim Healthcare Talks Idea Forum | Oncology Day
07/02/2019
MENLO PARK, Calif. , Feb. 07, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Replimune to Present at Two Upcoming Investor Conferences
07/02/2019
WOBURN, Mass., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced that Robert Coffin [...]
Adaptimmune to Report Fourth Quarter / Full Year 2018 Financial Results and Business Update on Wednesday, February 27, 2019
07/02/2019
PHILADELPHIA and OXFORD, United Kingdom, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the Fourth Quarter [...]
Sport Endurance Signs Letter of Intent to Acquire CBD Animal Health and Wellness Company, Bona Vida
07/02/2019
BROOKLYN, N.Y., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”), to be reincorporated as Better Choice Company, Inc., today announced that it has signed a Letter of Intent (“LOI”) [...]
CTD Reports Initial Data for Two Clinical Trials of Trappsol® Cyclo™ Provided Intravenously for Patients with Niemann-Pick Disease Type C
07/02/2019
ALACHUA, Fla., Feb. 07, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]
Arch Biopartners Awarded NRC-IRAP Funding to Further Develop Metablok Drug Program
07/02/2019
TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), today announced that the National Research Council – Industrial Research Assistance [...]
VBI Vaccines Announces Third Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients
07/02/2019
Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the study without modification Enrollment is complete in the high-dose study arm of Part A Expanded immunologic data and 6-month [...]
InspireMD to Report Fourth Quarter and Fiscal 2018 Financial Results and Provide Business Update on Tuesday, February 19
07/02/2019
Conference Call Scheduled for 8am Eastern Time TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of [...]
Avadel Pharmaceuticals Announces Restructuring to Focus on FT218 Clinical Development Program
07/02/2019
- Company cost structure expected to be reduced by $70 to $75 million in 2019 – - Approximately $100 million in cash and marketable securities at December 31, 2018 – DUBLIN, Ireland, Feb. 07, 2019 (GLOBE NEWSWIRE) -- [...]
Shockwave Appoints Laura Francis to Board of Directors
07/02/2019
SANTA CLARA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today [...]

Pages